DK151255C - Analogifremgangsmaade til fremstilling af n-alkynyl-n'-(omega-((5-substituerede-2-furyl)-alkylthio)alkyl)-derivater af nae-(substitueret)-guanidin eller af 1,1-diamino-2-(substitueret)-ethylen. - Google Patents

Analogifremgangsmaade til fremstilling af n-alkynyl-n'-(omega-((5-substituerede-2-furyl)-alkylthio)alkyl)-derivater af nae-(substitueret)-guanidin eller af 1,1-diamino-2-(substitueret)-ethylen.

Info

Publication number
DK151255C
DK151255C DK401679A DK401679A DK151255C DK 151255 C DK151255 C DK 151255C DK 401679 A DK401679 A DK 401679A DK 401679 A DK401679 A DK 401679A DK 151255 C DK151255 C DK 151255C
Authority
DK
Denmark
Prior art keywords
substituted
nae
guanidine
furyl
omega
Prior art date
Application number
DK401679A
Other languages
English (en)
Other versions
DK151255B (da
DK401679A (da
Inventor
Aldo Antonio Algieri
Ronnie Ray Crenshaw
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK401679A publication Critical patent/DK401679A/da
Publication of DK151255B publication Critical patent/DK151255B/da
Application granted granted Critical
Publication of DK151255C publication Critical patent/DK151255C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
DK401679A 1978-09-26 1979-09-25 Analogifremgangsmaade til fremstilling af n-alkynyl-n'-(omega-((5-substituerede-2-furyl)-alkylthio)alkyl)-derivater af nae-(substitueret)-guanidin eller af 1,1-diamino-2-(substitueret)-ethylen. DK151255C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94596878 1978-09-26
US05/945,968 US4203909A (en) 1978-09-26 1978-09-26 Furan compounds

Publications (3)

Publication Number Publication Date
DK401679A DK401679A (da) 1980-03-27
DK151255B DK151255B (da) 1987-11-16
DK151255C true DK151255C (da) 1988-05-24

Family

ID=25483767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK401679A DK151255C (da) 1978-09-26 1979-09-25 Analogifremgangsmaade til fremstilling af n-alkynyl-n'-(omega-((5-substituerede-2-furyl)-alkylthio)alkyl)-derivater af nae-(substitueret)-guanidin eller af 1,1-diamino-2-(substitueret)-ethylen.

Country Status (29)

Country Link
US (1) US4203909A (da)
JP (1) JPS5547670A (da)
KR (1) KR840001019B1 (da)
AT (1) AT376967B (da)
AU (1) AU525020B2 (da)
BE (1) BE879024A (da)
CA (1) CA1148556A (da)
CH (1) CH641794A5 (da)
CY (1) CY1275A (da)
DE (1) DE2938990A1 (da)
DK (1) DK151255C (da)
ES (1) ES8100284A1 (da)
FI (1) FI74959C (da)
FR (1) FR2437409A1 (da)
GB (1) GB2030985B (da)
GR (1) GR74126B (da)
HK (1) HK1485A (da)
HU (1) HU181408B (da)
IE (1) IE48946B1 (da)
IL (1) IL58300A (da)
IT (1) IT1164705B (da)
KE (1) KE3486A (da)
LU (1) LU81726A1 (da)
MY (1) MY8500948A (da)
NL (1) NL7907066A (da)
PH (1) PH16952A (da)
SE (1) SE446095B (da)
YU (1) YU41442B (da)
ZA (1) ZA794996B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
EP0057981A3 (en) 1981-02-09 1982-08-25 Beecham Group Plc Aromatic compounds, processes for their preparation and their use
WO1983002113A1 (en) * 1981-12-17 1983-06-23 Yuki, Hiroshi Propenylamine derivatives and drug containing same
PT76557B (en) * 1982-04-16 1986-01-21 Inke Sa Process for preparing furan derivatives and addition salts thereof and of pharmaceutical compositions containing the same
DE3343884A1 (de) * 1982-12-08 1984-06-14 Degussa Ag, 6000 Frankfurt Neue ethendiamin- und guanidin-derivate
NL8303965A (nl) * 1982-12-08 1984-07-02 Degussa Nieuwe etheendiamine- en guanidine-derivaten; werkwijze voor het bereiden daarvan; geneesmiddelen die ze bevatten; werkwijze voor het bereiden van dergelijke geneesmiddelen; toepassing van de verbindingen voor het bereiden van geneesmiddelen en in de geneeskunde.
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
HU196979B (en) * 1985-01-11 1989-02-28 Gyogyszerkutato Intezet Process for producing basic thioether and salt
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1553070A (en) 1975-05-21 1979-09-19 Smith Kline French Lab Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
CY1077A (en) * 1976-08-04 1980-12-27 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
DE2724070A1 (de) * 1977-05-27 1978-12-07 Bayerische Motoren Werke Ag Schaltvorrichtung fuer ausruestungsbauteilen von kraftfahrzeugen zugeordnete stromverbraucher
US4112234A (en) * 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines

Also Published As

Publication number Publication date
DE2938990C2 (da) 1987-09-03
DK151255B (da) 1987-11-16
GB2030985B (en) 1982-11-17
FR2437409A1 (fr) 1980-04-25
PH16952A (en) 1984-04-24
CA1148556A (en) 1983-06-21
ES484446A0 (es) 1980-11-01
AU525020B2 (en) 1982-10-14
JPS618835B2 (da) 1986-03-18
FI74959C (fi) 1988-04-11
LU81726A1 (fr) 1980-05-07
BE879024A (fr) 1980-03-26
FR2437409B1 (da) 1983-09-16
YU41442B (en) 1987-06-30
SE446095B (sv) 1986-08-11
CY1275A (en) 1985-03-08
GR74126B (da) 1984-06-06
DK401679A (da) 1980-03-27
KE3486A (en) 1985-01-25
AU5086479A (en) 1980-04-03
US4203909A (en) 1980-05-20
HK1485A (en) 1985-01-11
ATA630179A (de) 1984-06-15
HU181408B (en) 1983-07-28
YU228479A (en) 1983-02-28
IT1164705B (it) 1987-04-15
GB2030985A (en) 1980-04-16
IT7950309A0 (it) 1979-09-20
NL7907066A (nl) 1980-03-28
AT376967B (de) 1985-01-25
IE48946B1 (en) 1985-06-26
IL58300A0 (en) 1979-12-30
ZA794996B (en) 1980-10-29
FI792974A (fi) 1980-03-27
KR840001019B1 (ko) 1984-07-20
CH641794A5 (de) 1984-03-15
DE2938990A1 (de) 1980-06-04
SE7907953L (sv) 1980-03-27
FI74959B (fi) 1987-12-31
MY8500948A (en) 1985-12-31
ES8100284A1 (es) 1980-11-01
IE791817L (en) 1980-03-26
JPS5547670A (en) 1980-04-04
IL58300A (en) 1984-01-31

Similar Documents

Publication Publication Date Title
DK462380A (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf
DK144010C (da) Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf
DK150512C (da) Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf
DK153787C (da) Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
DK149850C (da) Analogifremgangsmaade til fremstilling af 5-(3,4-disubst. phenyl)-oxazolidinoner eller thiazolidinoner eller de tilsvarende thioner
DK149111C (da) Analogifremgangsmaade til fremstilling af histidinderivater eller syreadditionssalte deraf
DK154766C (da) Fremgangsmaade til fremstilling af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol i specifik form
DK147858C (da) Analogifremgangsmaade til fremstilling af 5'-deoxy-5-fluorcytidin eller 5'-deoxy-5-fluoruridin eller fysiologisk tolerable syreadditionssalte dera
DK160092C (da) Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolin eller ikke-toxiske syreadditionssalte deraf
DK151255C (da) Analogifremgangsmaade til fremstilling af n-alkynyl-n'-(omega-((5-substituerede-2-furyl)-alkylthio)alkyl)-derivater af nae-(substitueret)-guanidin eller af 1,1-diamino-2-(substitueret)-ethylen.
DK260579A (da) Fremgangsmaade til fremstilling af 14,15-methylenderivater af oestranraekken
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
DK243477A (da) Fremgangsmade til fremstilling af 10,19-dihydrovitamin d forbindelser
DK146281C (da) Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf
DK140695B (da) Analogifremgangsmaade til fremstilling af 2,4-diamo-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
DK382979A (da) Fremgangsmaade til fremstilling af 3" , 4"-diacyltylosinderivater
DK147943C (da) Analogifremgangsmaade til fremstilling af 4''-deoxy-4''-acylamidoderivater af oleandomycin-forbindelser, erythromycin-forbindelser eller erythromycin-6,9-hemiketal-forbindelser
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK173379A (da) Fremgangsmaade til fremstilling af 6alfa-halogen-3-keto-delta 1,4-pregnadienderivater
DK430379A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK150597C (da) Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf
DK185977A (da) Fremgangsmade til fremstilling af 1,3-dihydroheteroarylspiro (isobenzofuraner)
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf
DK158457C (da) Analogifremgangsmaade til fremstilling af 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaensyre eller salte heraf

Legal Events

Date Code Title Description
PBP Patent lapsed